Su idioma
Su idioma
Fucithalmic®

Look again at how you treat bacterial conjunctivitis or blepharitis.

Patient Choice

According to global market research conducted in five countries in 278 patients, Fucithalmic® was preferred by 62% of patients compared with tobramycin, 66% of patients preferred Fucithalmic® over chloramphenicol and 85% preferred Fucithalmic®compared with moxifloxacin.1
Fucithalmic Graphs English 05

REFERENCES:

  1. Global Market Research conducted on bacterial conjunctivitis in 5 countries in 278 patients (Concordia Rx - Fucithalmic® . Bacterial Conjunctivitis: Patient Market Research - Data on File. June 2018)